Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Am J Gastroenterol. 2017 Apr 4;112(8):1256–1264. doi: 10.1038/ajg.2017.82

Table 3.

1, 3 and 5-year survival rate (95% CI) for overall and cancer-specific survival

No prior BE diagnosis
(N=4401)		 Prior BE diagnosis
(N=577)
Overall survival
 1 year 43% (41–44%) 62% (57–65%)
 3 years 17% (16–18%) 39% (35–43%)
 5 years 11% (10–12%) 31% (27–35%)
Cancer-specific survival
 1 year 50% (49–52%) 70% (66–74%)
 3 years 26% (24–27%) 52% (48–57%)
 5 years 21% (20–22%) 47% (42–51%)

BE, Barrett’s Esophagus; CI, confidence interval; SEER, Surveillance, Epidemiology, and End Results.